Oklahoma City, Oklahoma
< 0 mi
Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients
Interventional • Run by National Cancer Institute (NCI)
Recurrent Lung Non-Small Cell Carcinoma
All Conditions(9)